På baggrund af gennemgangen af data og respons vurderede CHMP, at ansøgningen om Rapinyl kunne godkendes, forudsat at ansøgeren besvarer listen med de resterende spørgsmål tilfredsstillende.
Based on the review of the data and the responses, the CHMP considered the application for Rapinyl to be approvable, provided that the Applicant addressed the List of Remaining Issues satisfactorily.